Aluna, an artificial intelligence-powered lung health platform, raised $15.3 million in a series B financing round.
The company's platform allows patients to remotely transfer lung health data to clinicians by blowing into a spirometer. Next, the patient can record symptoms and environmental factors in Aluna's app, according to a Feb. 1 Aluna news release.
Aluna is used by patients managing their asthma, cystic fibrosis and COPD. The financing round brings the company's total raised to $27 million.
"As we head into 2023, we plan to grow Aluna's product and its scale with this funding and the support of our partners," Aluna COO Jason Hochman said in the release.
Subscribe to the following topics: #ai#seriesb
/w=3840,quality=90,fit=scale-down)
